IMGG has been my best runner this year and LONG ovedue. Their news hasn't changed one bit: still waiting for FDA approval to validate its machine/technology. It could run like NEPH, but in IMGG's case, the implications when approval comes are huge by comparison.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.